Autopsy report · NCT05349019

A Natural History Study of Patients With G2019S LRRK2 Parkinson's Disease

“Sponsor stopped the study”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 months before it stopped.
• 22 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Escape Bio, Inc.

Sponsor type

Industry

Conditions

Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene

Interventions

Observational

Participants

22

Sites

1

Countries

United States

Trials that died the same way

• Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
  “Study was stopped by the Sponsor” (96% match in meaning)
• Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum
  “The sponsor stopped the study.” (96% match in meaning)
• the Health Crisis at the Healthcare Professionals, Careers and Non-careers, a Month After the Containment Period
  “the sponsor decided to stop the study” (94% match in meaning)
• Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)
  “The sponsor has decided to stop the study” (92% match in meaning)
• Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
  “Study has been stopped by sponsor decision.” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.